Show notes
In this powerful ScaleUp Radio Shorts episode, Kevin Brent and Granger Forson contrast two founders tackling very different ends of the healthcare and life sciences spectrum:
- Michael Colling-Tuck, founder of Agency Medical Marketing, is on a mission to ensure life-changing innovations get adopted by clinicians and patients.
- Prasun Chakraborty, founder of Genevation, is developing personalised cancer vaccines using cutting-edge AI and immunotherapy.
One is solving the problem of visibility and market traction. The other is solving for scientific possibility and clinical impact. Yet both share a relentless sense of purpose and founder resilience.
What You’ll Learn:
✅ The commercial vs scientific ends of the innovation lifecycle
✅ How founder motivation shapes business strategy
✅ Different approaches to funding, operations and visibility
✅ Why isolation, pressure and resilience are universal for founders
Standout Quotes:
“Only 5% of life-changing medical innovations succeed – not because they don’t work, but because no one knows about them.” – Michael
“I think like a patient so I can build for the patient.” – Prasun
Key Takeaway:
Innovation dies without commercial traction, and commercial traction is meaningless without innovation. Founders must either build the bridge—or be the breakthrough.